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A compact clinically compatible fluorescence lifetime imaging microscopy (FLIM) system was designed and
built for intraoperative disease diagnosis and validated in vivo in a hamster oral carcinogenesis model. This
apparatus allows for the remote image collection via a flexible imaging probe consisting of a gradient index
objective lens and a fiber bundle. Tissue autofluorescence (337 nm excitation) was imaged using an intensi-
fied CCD with a gate width down to 0.2 ns. We demonstrate a significant contrast in fluorescence lifetime
between tumor 1.77±0.26 ns and normal 2.50±0.36 ns tissues at 450 nm and an over 80% intensity de-
crease at 390 nm emission in tumor versus normal areas. The time-resolved images were minimally affected
by tissue morphology, endogenous absorbers, and illumination. These results demonstrate the potential of
FLIM as an intraoperative diagnostic technique. © 2009 Optical Society of America
OCIS codes: 170.2520, 170.2150, 170.3650, 110.2350, 170.6935.Autofluorescence of biological tissues provides abun-
dant intrinsic signals revealing changes in chemical
composition, metabolism, and morphology [1,2] ow-
ing to either pathologic conditions or response to
therapy. Label-free fluorescence spectroscopy and im-
aging have been recognized as powerful tools for dis-
crimination of diseased areas with high specificity
and sensitivity [1,3,4]. Encouraging results have
been reported for autofluorescence in vivo cancer di-
agnoses including oral, cervical, and brain tumors
[1,4,5]. However, current fluorescence diagnostic
techniques relying on spectrum and intensity analy-
ses are challenged by the broad and overlapping
emission spectra of endogenous fluorophores, the
nonuniform illumination caused by the irregular tis-
sue surface, and the distorted emission owing to en-
dogenous absorbers. Fluorescence lifetime measure-
ment can overcome such challenges because of the
relative independence to the absolute intensity value
[3,5]. In addition, the intrinsic fluorescence decay
(lifetime) not only provides a means of differentiating
fluorophores with overlapped spectra but also can be
used to monitor intracellular metabolism fluctua-
tions or local environmental fluctuations [2,3]. Con-
sequently, fluorescence lifetime imaging microscopy
(FLIM) is a promising imaging modality for diagnosis
and image-guided interventions. In past decades,
FLIM has been widely used for studies in biology, bio-
physics, and biochemistry, but few reports appeared
on the ex vivo/in vivo examination of tissue [6,7], and
only one work approached to endoscopic FLIM for
disease diagnosis in vivo with a rigid bronchoscope
[8].
The FLIM apparatus (Fig. 1) consists of a gated in-
tensified CCD (ICCD) camera, a pulsed laser, a flex-
ible fiber-optic based endoscope, and a filter wheel.
0146-9592/09/132081-3/$15.00 ©This instrument is an improvement on a prototype
system we reported previously [9]. Tissue autofluo-
rescence induced by pulsed nitrogen laser (337 nm,
700 ps pulse width, MNL 205, LTB Lasertechnik,
Berlin) was collected using the gradient index
(GRIN) lens (NA of 0.5, 0.5 mm diameter, 4 mm field
of view, GRINTECH GmbH, Jena) cemented to a fi-
ber image guide (0.6 mm diameter, 2 m long, 10,000
fibers). A 20 microscope objective and a 150 mm fo-
cal length achromatic lens were used to magnify fluo-
rescence images to the ICCD. Filter 390/70 nm (cen-
ter wavelength/bandwidth) (F1) and filter 450/65 nm
(F2) were switched by a motorized filter wheel.
Advanced electro-optics and fiber optics enabled
the compact and robust design of this FLIM appara-
tus. One of the key components is the compact ICCD
(4 Picos, Stanford Computer Optics, Berkeley, Cali-
fornia) with fully integrated electronic and optical de-
vices in a small enclosure 24 cm14 cm11 cm,
including a multichannel plate (MCP) image intensi-
fier, relay lenses, a CCD camera, a delay generator,
and a high voltage power supply. To our knowledge
this is the first application of the 4 Picos camera to
fluorescence lifetime imaging. It has a gate width
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Fig. 1. (Color online) Compact FLIM system using a gated
ICCD, a 700 ps pulsed laser, and a flexible fiber endoscope
for tissue diagnosis in vivo.
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200 kHz. The spatial resolution of the system was
measured as 35 m using a USAF test chart (Ed-
mund Optics). The temporal resolution was tested as
0.5 ns based on the measurement of a standard
short-lived fluorophore Rose Bengal and the analysis
of instrument response function. Limited by the rep-
etition rate 50 Hz of the laser, the typical acquisi-
tion time for tissue was 120 s. Images were processed
using a graphical user interface programmed in
MATLAB (The MathWorks Inc.). The Laguerre poly-
nomial deconvolution was employed to retrieve life-
times rapidly without requiring a priori assumption
about the decay profile [5,9].
The ability of the FLIM apparatus to resolve fluo-
rophores with overlapping spectra was examined on
a series of fluorophores with lifetimes distributed in a
broad range (1–12 ns): coumarin 1 (C-1, in methanol),
coumarin 120 (C-120, in methanol), and
9-Anthracenecarbonitrile (9CA, in ethanol, Sigma-
Aldrich). Three dyes in separate capillaries were im-
aged and analyzed together. Figure 2 depicts the fluo-
rescence intensity image, the lifetime map, and the
lifetime histogram. The means of average lifetimes of
C-1, C-120, and 9CA were measured as 1.6±0.04
(standard deviation), 3.0±0.08, and 11.2±0.64 ns, re-
spectively. These results were in agreement with pre-
vious work [10]. The surface curvature of capillaries
clearly affected the intensity image showing a non-
uniform emission [Fig. 2(a)]. However, a uniform life-
time map was retrieved from each capillary [Fig.
2(b)]. This indicates that FLIM is more robust than
the intensity measurement for samples with local
height variations. This is an important feature for in-
vestigations of tissue where a uniform illumination
cannot be easily achieved over the area of interest
owing to its irregular surface.
Finally this FLIM system was validated in vivo
with a hamster buccal pouch carcinogenesis model
for tumor demarcation. The right cheek of ten Syrian
golden hamsters was painted with 0.5% 7,12-
dimethylbenz[a]anthracene (DMBA) three times a
week until lesions developed. The left buccal pouch
was used as control. Two hamsters without treat-
ment were imaged also as true controls. After ani-
mals were anesthetized with ketamine and xylazine,
the cheek pouch was inverted and imaged with the
probe perpendicular to the regions of interest. Biopsy
samples were taken for histopathologic analysis
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Fig. 2. (Color online) Evaluation of the FLIM apparatus
on standard fluorophores with overlapping emission spec-
tra but different lifetimes: (a) intensity image, (b) lifetime
image, and (c) lifetime histogram. In (c) the small peak
(SFL) between C-1 and C-120 is the scattered fluorescence
light within the capillary sidewalls.(H&E and trichrome stains) and were graded as nor-
mal, dysplastic, carcinoma in situ, or squamous cell
carcinoma. To have a consistent data processing, the
regular method of tissue and region selection was
based on (1) vision inspection during experiments by
a surgeon/otolaryngologist and (2) histopathologic
evaluation of a pathologist after experiments.
Figure 3 shows fluorescence intensity and lifetime
images of normal cheek mucosa and carcinoma in
situ recorded with F2. From the normal mucosa, the
intensity image [Fig. 3(a)] visualizes blood vessel
branches clearly, which is caused by the fluorescence
reabsorption by the blood hemoglobin. In contrast,
the lifetime image [Fig. 3(b)] exhibits a uniform
mapping across the entire area with F2control
=1.83±0.10 ns. This suggests that the fluorescence
emission of normal cheek originates from the same
fluorophore(s). Also, it underscores that the presence
of endogenous absorbers in tissues affects the steady
state intensity much more than the fluorescence life-
time. Figures 3(c) and 3(d) display the fluorescence
intensity and the lifetime images of a carcinoma tu-
mor with surrounding normal tissue from a diseased
hamster cheek. The upper right region was diag-
nosed as carcinoma in situ and exhibited weak
fluorescence with a short lifetime F2tumor
=1.30±0.08 ns when compared with the surround-
ing normal area characterized by strong fluorescence
with a relatively long lifetime F2normal=1.56
±0.10 ns. Lifetime histograms in Fig. 3 show an ob-
vious shift of tumor fluorescence decays toward the
lower level. Figure 3 images were demonstrated with
the particular interest in the margin of tumor/
normal, intensity and lifetime contrast, and vessel
networks but the lifetime values (both tumor and
normal) were in the low range of the statistic results.
By combining both lifetime and intensity information
the discrimination was even more obvious as seen in
Fig. 3(f). Similar trends between normal versus dis-
eased areas were observed for all stages of the tumor
progression including dysplasia, carcinoma in situ,
and carcinoma, but tumor stages could not be classi-
fied clearly in this validation with limited data sets.
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Fig. 3. (Color online) Fluorescence images of hamster
cheek in vivo. Normal buccal pouch mucosa: (a) intensity
image, (b) lifetime image, and (e) lifetime histogram. Car-
cinoma in situ with surrounding tissue: (c) intensity image,
(d) lifetime map, and its histogram (f). (g) A color picture
under white light. (h) Intensity-weighted lifetime image
from (c) and (d). Two histogram regions were selected refer-
ring to the bright field and fluorescence intensity images.
Each region covered about 60%–80% central area for both
tumor and normal.
July 1, 2009 / Vol. 34, No. 13 / OPTICS LETTERS 2083A total of ten carcinogen-exposed hamsters were ex-
amined with 21 sites from tumors and 14 sites from
normal areas. The average lifetime of the diseased
sites was 1.77±0.26 ns, which was 29% lower than
that from the control of 2.50±0.36 ns. These results
suggest that fluorescence lifetime at 450 nm provides
a means to differentiate diseased areas from normal
tissue in carcinoma diagnosis.
With filter F1 a strong fluorescence emission was
observed for normal cheeks in contrast to tumor ar-
eas, where the intensity decreased over 80%. The
fluorescence lifetime of F1normal=3.17±0.42 ns was
longer than that at F2 emission. In this study, the
very weak fluorescence with a low signal-to-noise ra-
tio from tumor caused difficulties in retrieving life-
time information.
As demonstrated by previous studies, the autofluo-
rescence of oral mucosa upon UV excitation primarily
originates from collagen and nicotinamide adenine
dinucleotide (NADH) [1,4,7,11]. Here, fluorescence
signal through F1 most likely corresponds to collagen
(peak emission at 380–400 nm) whereas that through
F2 is mainly from NADH (450–460 nm). Collagen
cross links are considered as the dominant contribu-
tors to the autofluorescence of normal oral mucosa
with fluorescence lifetimes in the range of 2.5–5 ns
[1,2,9]. NADH, a coenzyme associated with cellular
metabolism, is the main contributor to the fluores-
cence emission of oral carcinoma [1,4,7]. Free NADH
has a fluorescence lifetime of less than 0.5 ns, while
protein-bound NADH presents longer lifetime values,
typically above 1 ns [3,7]. In agreement with these
earlier reports, F2 at 450/65 nm was considered as an
adequate subband for carcinoma examination in this
study. The decrease in intensity and lifetime of the
autofluorescence from cancerous sites, consistent
with previous results [1,4,7,10], reflects the biochemi-
cal compositional changes within tissue, as the rela-
tive contribution of NADH (short lifetimes and low
quantum yield) increases during the progression of
metabolically active cancer cells while the ratio of
collagen (long lifetime and high quantum yield) de-
clines owing to the degradation of connective tissue
matrix.
The validation of the portable endoscopic FLIM for
oral carcinoma diagnosis in vivo has demonstrated
the capability of FLIM to discriminate malignant tis-
sue from normal mucosa by label-free autofluores-
cence examination. Using information from both in-
tensity and lifetime, FLIM is an effective method tocharacterize endogenous fluorophores in living sys-
tems. It can be potentially used to perform optical de-
lineation of tumors during surgical interventions or
noninvasive cancer screening. Further improvements
are still underway, including the use of a megahertz
fiber laser as the excitation source to achieve video-
rate imaging with a much shorter acquisition time
and a user-friendly interface for rapid image process-
ing and tissue classification.
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